Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Sell
40
HYPMY Quote, Financials, Valuation and Earnings
Last price:
$5.02
Seasonality move
:
-4.93%
Day range:
$5.00 - $5.02
52-week range:
$2.64 - $5.92
Dividend yield:
4.08%
P/E ratio:
21.06x
P/S ratio:
2.64x
P/B ratio:
1.56x
Volume:
453.1K
Avg. volume:
208K
1-year change:
-5.33%
Market cap:
$3.2B
Revenue:
$1.4B
EPS (TTM):
$0.24
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Hypera SA has -- downside to fair value with a price target of -- per share.
HYPMY vs. S&P 500
-
Over the past 5 trading days, Hypera SA has underperformed the S&P 500 by -0.2% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Hypera SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hypera SA revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Hypera SA reported revenues of $184.4M.
Earnings Growth
-
Hypera SA earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Hypera SA reported earnings per share of -$0.04.
Enterprise value:
4.5B
EV / Invested capital:
--
Price / LTM sales:
2.64x
EV / EBIT:
20.98x
EV / Revenue:
3.72x
PEG ratio (5yr expected):
16.41x
EV / Free cash flow:
13.76x
Price / Operating cash flow:
9.78x
Enterprise value / EBITDA:
16.90x
Gross Profit (TTM):
$684.1M
Return On Assets:
3.37%
Net Income Margin (TTM):
12.59%
Return On Equity:
7.07%
Return On Invested Capital:
3.83%
Operating Margin:
-20.81%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.6B | $1.2B | $368.9M | $184.4M | |
| Gross Profit | $952.7M | $1B | $684.1M | $225.3M | $87M | |
| Operating Income | $491.7M | $515.9M | $188M | $117.5M | -$38.4M | |
| EBITDA | $554.4M | $601.1M | $265.7M | $141.5M | -$18M | |
| Diluted EPS | $0.51 | $0.54 | $0.24 | $0.12 | -$0.04 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $894M | $1.3B | $1.4B | $1.7B | $1B | |
| Total Assets | $3.1B | $4.3B | $4.4B | $5B | $4.2B | |
| Current Liabilities | $396.1M | $737.9M | $691.3M | $955.9M | $809.1M | |
| Total Liabilities | $1.5B | $2.2B | $2.3B | $2.7B | $2.2B | |
| Total Equity | $1.6B | $2.1B | $2.1B | $2.3B | $2B | |
| Total Debt | $1.2B | $1.7B | $1.7B | $2.1B | $1.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $393.8M | $518.8M | $473.8M | $96.8M | $97.2M | |
| Cash From Investing | -$185.3M | -$147M | -$121.8M | -$21.3M | -$32.7M | |
| Cash From Financing | -$306.1M | $33M | -$628.6M | $44.4M | -$64.4M | |
| Free Cash Flow | $223.3M | $362.9M | $326.5M | $64.4M | $61.4M | |
HYPMY
Sector
Market Cap
$3.2B
$34.4M
Price % of 52-Week High
84.75%
48.88%
Dividend Yield
4.08%
0%
Shareholder Yield
11.1%
-1.01%
1-Year Price Total Return
-5.33%
-37.36%
Beta (5-Year)
0.812
0.614
Dividend yield:
4.08%
Annualized payout:
$0.17
Payout ratio:
89.28%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$4.95
200-day SMA
Buy
Level
$3.84
Bollinger Bands (100)
Buy
Level
3.39 - 4.65
Chaikin Money Flow
Buy
Level
920.1K
20-day SMA
Buy
Level
$4.87
Relative Strength Index (RSI14)
Buy
Level
58.38
ADX Line
Sell
Level
10.3
Williams %R
Sell
Level
-16.5484
50-day SMA
Buy
Level
$4.57
MACD (12, 26)
Buy
Level
1.35
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
978.4K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Buy
CA Score
(Annual)
Level (-0.0755)
Buy
Beneish M-Score
(Annual)
Level (-3.0331)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.147)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and the Non-Retail Market.
Stock Forecast FAQ
In the current month, HYPMY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HYPMY average analyst price target in the past 3 months is --.
-
Where Will Hypera SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hypera SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Hypera SA?
Analysts are divided on their view about Hypera SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hypera SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Hypera SA's Price Target?
The price target for Hypera SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HYPMY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hypera SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HYPMY?
You can purchase shares of Hypera SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hypera SA shares.
-
What Is The Hypera SA Share Price Today?
Hypera SA was last trading at $5.02 per share. This represents the most recent stock quote for Hypera SA. Yesterday, Hypera SA closed at $5.02 per share.
-
How To Buy Hypera SA Stock Online?
In order to purchase Hypera SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 6.55% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is up 1.36% over the past day.
Sell
42
VLCN alert for Jul 17
Volcon [VLCN] is up 212.87% over the past day.
